Celtic Therapeutics Starts Antibody-Drug Conjugates Unit

Celtic Therapeutics Management LLLP, a private-equity firm co-founded by a former Pfizer Inc. executive, is starting a company to develop therapies that marry antibodies with cancer-killing drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.